Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Subscribe
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Special report
: The Fierce 50 of 2024
ASCO 2020
Pharma
Has AstraZeneca finally found a place for tremelimumab?
AZ's tremelimumab has so far suffered a host of clinical failures. But new trial results show the company might be able to use the drug in a new way.
Carly Helfand
May 31, 2020 4:49pm
Merck pads case for liver cancer nod with Keytruda-Lenvima data
May 31, 2020 1:56pm
AZ, Daiichi tout Enhertu victory in tough stomach cancer
May 29, 2020 8:00am
Gilead CAR-T Yescarta sees its shot in slow-growing lymphoma
May 29, 2020 8:00am
Pfizer, Merck KGaA's Bavencio lines up for bladder cancer edge
May 28, 2020 5:00pm
AstraZeneca's Tagrisso cuts lung cancer recurrence by 83%
May 28, 2020 5:00pm
